Ascendis Pharma Files 8-A12B/A Amendment
Ticker: ASND · Form: 8-A12B/A · Filed: Apr 20, 2026 · CIK: 0001612042
Sentiment: neutral
Topics: sec-filing, registration, amendment
TL;DR
Ascendis Pharma filed an 8-A12B/A amendment on 4/20/26. Standard SEC filing.
AI Summary
Ascendis Pharma A/S filed an amendment to its registration of securities on Form 8-A12B/A on April 20, 2026. This filing relates to the registration of securities under Section 12(b) of the Securities Exchange Act of 1934. The company's business address is Tuborg Boulevard 12, Hellerup, Denmark.
Why It Matters
This filing indicates an update or amendment to Ascendis Pharma's securities registration, which is a standard regulatory step for publicly traded companies.
Risk Assessment
Risk Level: low — Form 8-A12B/A filings are routine amendments to securities registration and typically do not represent new material risks.
Key Numbers
- 2026-04-20 — Filing Date (Date of the 8-A12B/A amendment filing)
Key Players & Entities
- Ascendis Pharma A/S (company) — Filer
- 0001612042 (company) — CIK number
- 001-36815 (company) — File number
- TUBORG BOULEVARD 12 HELLERUP Denmark (company) — Business Address
FAQ
What is the purpose of an 8-A12B/A filing?
An 8-A12B/A filing is an amendment to a registration statement for securities to be listed on a national securities exchange, as required by Section 12(b) of the Securities Exchange Act of 1934.
When was this specific amendment filed?
This amendment was filed on April 20, 2026.
What is the CIK number for Ascendis Pharma A/S?
The CIK number for Ascendis Pharma A/S is 0001612042.
Where is Ascendis Pharma A/S located?
Ascendis Pharma A/S has its business address at Tuborg Boulevard 12, Hellerup, Denmark.
What is the file number associated with this registration?
The file number associated with this registration is 001-36815.
Filing Details
This Form 8-A12B/A (Form 8-A12B/A) was filed with the SEC on April 20, 2026 regarding Ascendis Pharma A/S (ASND).